ArticleAlzheimer's research & therapy2024
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
Lawrence S Honig et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it